BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33770222)

  • 1. Value of bowel preparation techniques for prostate MRI: a preliminary study.
    Schmidt C; Hötker AM; Muehlematter UJ; Burger IA; Donati OF; Barth BK
    Abdom Radiol (NY); 2021 Aug; 46(8):4002-4013. PubMed ID: 33770222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hyoscine butylbromide on prostate multiparametric MRI anatomical and functional image quality.
    Slough RA; Caglic I; Hansen NL; Patterson AJ; Barrett T
    Clin Radiol; 2018 Feb; 73(2):216.e9-216.e14. PubMed ID: 28803622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.
    Gondo T; Hricak H; Sala E; Zheng J; Moskowitz CS; Bernstein M; Eastham JA; Vargas HA
    Eur Radiol; 2014 Dec; 24(12):3161-70. PubMed ID: 25100337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
    Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Quantitative T2-Mapping Compared to Conventional and Advanced Diffusion Weighted Imaging Techniques for Multiparametric Prostate MRI in Men with Hip Prosthesis.
    Sathiadoss P; Schieda N; Haroon M; Osman H; Alrasheed S; Flood TA; Melkus G
    J Magn Reson Imaging; 2022 Jan; 55(1):265-274. PubMed ID: 34223675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-to-high b value DWI ratio approaches in multiparametric MRI of the prostate: feasibility, optimal combination of b values, and comparison with ADC maps for the visual presentation of prostate cancer.
    Xi Y; Liu A; Olumba F; Lawson P; Costa DN; Yuan Q; Khatri G; Yokoo T; Pedrosa I; Lenkinski RE
    Quant Imaging Med Surg; 2018 Jul; 8(6):557-567. PubMed ID: 30140618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
    Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
    J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy.
    Giannarini G; Cereser L; Como G; Bonato F; Pizzolitto S; Valotto C; Ficarra V; Dal Moro F; Zuiani C; Girometti R
    Acta Radiol; 2021 Jul; 62(7):949-958. PubMed ID: 32718179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal preparation significantly improves prostate imaging quality: Assessment of the PI-QUAL score with visual grading characteristics.
    Arnoldner MA; Polanec SH; Lazar M; Noori Khadjavi S; Clauser P; Pötsch N; Schwarz-Nemec U; Korn S; Hübner N; Shariat SF; Helbich TH; Baltzer PAT
    Eur J Radiol; 2022 Feb; 147():110145. PubMed ID: 35007983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.
    Eldred-Evans D; Neves JB; Simmons LAM; Kanthabalan A; McCartan N; Shah TT; Arya M; Charman SC; Freeman A; Moore CM; Punwani S; Emberton M; Ahmed HU
    BJU Int; 2020 Mar; 125(3):391-398. PubMed ID: 31733173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
    Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
    Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
    Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
    Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmented diffusion-weighted imaging of the prostate: Application to transperineal in-bore 3T MR image-guided targeted biopsy.
    Fedorov A; Tuncali K; Panych LP; Fairhurst J; Hassanzadeh E; Seethamraju RT; Tempany CM; Maier SE
    Magn Reson Imaging; 2016 Oct; 34(8):1146-54. PubMed ID: 27240900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving reader accuracy and specificity with the addition of hybrid multidimensional-MRI to multiparametric-MRI in diagnosing clinically significant prostate cancers.
    Lee G; Chatterjee A; Harmath C; Karademir I; Engelmann R; Yousuf A; Islam S; Karczmar G; Oto A; Giurcanu M; Antic T; Eggener S
    Abdom Radiol (NY); 2023 Oct; 48(10):3216-3228. PubMed ID: 37358605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convolutional Neural Networks for Automated Classification of Prostate Multiparametric Magnetic Resonance Imaging Based on Image Quality.
    Cipollari S; Guarrasi V; Pecoraro M; Bicchetti M; Messina E; Farina L; Paci P; Catalano C; Panebianco V
    J Magn Reson Imaging; 2022 Feb; 55(2):480-490. PubMed ID: 34374181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors.
    Marino MA; Avendano D; Sevilimedu V; Thakur S; Martinez D; Lo Gullo R; Horvat JV; Helbich TH; Baltzer PAT; Pinker K
    Eur J Radiol; 2022 Nov; 156():110523. PubMed ID: 36122521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.
    Almansour H; Afat S; Fritz V; Schick F; Nachbar M; Thorwarth D; Zips D; Müller AC; Nikolaou K; Othman AE; Wegener D
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
    Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
    J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.